Skip to content

Does Pilocarpine Dilate or Constrict? Understanding the Miosis Effect

3 min read

First isolated in 1874, pilocarpine has been used in ophthalmology for over a century, famously known for its effect on pupil size. So, does pilocarpine dilate or constrict the pupil? The answer is clear: it causes the pupil to constrict, a process known as miosis.

Quick Summary

Pilocarpine is a cholinergic agonist that causes miosis, or pupil constriction, by stimulating the iris sphincter muscle. This effect is used to treat conditions such as glaucoma and presbyopia.

Key Points

  • Pupil Constriction (Miosis): Pilocarpine is a miotic agent that constricts the pupil by stimulating the iris sphincter muscle.

  • Cholinergic Agonist: As a cholinergic agonist, it mimics the action of the neurotransmitter acetylcholine to cause smooth muscle contraction.

  • Glaucoma Treatment: In eye drops, it lowers intraocular pressure by enhancing the drainage of aqueous humor from the eye.

  • Presbyopia Therapy: New formulations constrict the pupil to create a pinhole effect, improving near vision for age-related difficulties.

  • Systemic Use: Oral tablets are used to treat dry mouth associated with Sjögren's syndrome or radiation therapy.

  • Common Side Effects: Ocular side effects can include headache, brow ache, and temporary blurred vision.

In This Article

Pilocarpine is a naturally occurring alkaloid that functions as a cholinergic agonist, meaning it mimics the effects of the neurotransmitter acetylcholine. In ophthalmology, it is primarily known for causing miosis, a reduction in pupil size. Understanding how pilocarpine achieves this constriction and its various applications is essential to appreciating its medical significance.

How Pilocarpine Causes Pupil Constriction (Miosis)

Pilocarpine's action on the pupil is mediated through the parasympathetic nervous system, which utilizes acetylcholine to constrict the pupil via muscarinic acetylcholine receptors. Pilocarpine is a muscarinic receptor agonist, specifically targeting the M3 subtype found in the iris sphincter muscle. By activating these receptors, pilocarpine causes the iris sphincter muscle to contract, leading to a decrease in pupil size, or miosis.

Additionally, pilocarpine causes contraction of the ciliary muscle, which helps to open the trabecular meshwork. This action enhances the drainage of aqueous humor, thus lowering intraocular pressure.

Key Therapeutic Uses of Pilocarpine

Pilocarpine's miotic effect and ability to lower intraocular pressure make it useful for several conditions, including certain eye disorders and systemic dryness.

Treating Glaucoma

Historically a primary treatment for glaucoma, pilocarpine remains relevant in managing this condition, which is characterized by elevated intraocular pressure. By opening the trabecular meshwork via ciliary muscle contraction, pilocarpine increases the outflow of aqueous humor, effectively reducing IOP and helping to protect the optic nerve. While often replaced by newer drugs for long-term management, it is still employed in specific situations like acute angle-closure glaucoma and pre-surgical preparation.

Correcting Presbyopia

More recently, pilocarpine, in lower concentrations (e.g., Vuity™), has been approved for treating presbyopia, the age-related loss of near focusing ability. This works by inducing miosis to create a pinhole effect, increasing the depth of field and improving near vision without the need for reading glasses.

Managing Dry Mouth (Xerostomia)

Beyond its ophthalmic uses, oral pilocarpine tablets stimulate muscarinic receptors in salivary glands, increasing saliva production. This is a recognized treatment for dry mouth in patients with Sjögren's syndrome or those who have undergone radiation therapy for head and neck cancer. This helps alleviate discomfort and associated complications.

Comparison of Pilocarpine (Miosis) vs. Mydriatics (Dilation)

Comparing pilocarpine to mydriatic agents, which dilate the pupil (like atropine), clarifies its function:

Feature Pilocarpine (Miotic) Atropine (Mydriatic)
Mechanism Stimulates muscarinic receptors, causing iris sphincter muscle contraction. Blocks muscarinic receptors, relaxing the iris sphincter muscle.
Pupil Effect Constricts the pupil (miosis). Dilates the pupil (mydriasis).
Drug Class Cholinergic agonist. Anticholinergic agent.
Common Uses Glaucoma, presbyopia, reversal of dilation. Dilated eye exams, treating amblyopia.
Effect on Focus Can cause accommodative spasm, leading to temporary blurred vision. Causes cycloplegia (paralysis of focusing muscle), leading to blurred near vision.
Night Vision Often reduces night vision due to smaller pupil size. Light sensitivity (photophobia) due to larger pupil size.

Important Side Effects and Precautions

Pilocarpine can cause side effects due to its action on muscarinic receptors. Ocular side effects may include brow ache, headache, temporary blurred vision, and reduced night vision. There is also a rare risk of retinal detachment, particularly in those with existing retinal conditions. A retinal exam before starting treatment is recommended. Systemic side effects from oral tablets can include increased sweating, nausea, diarrhea, and increased urinary frequency. Caution is advised for patients with certain medical conditions like asthma or heart disease, and it is important to discuss your medical history with a doctor.

Conclusion

In summary, pilocarpine definitively causes pupil constriction (miosis). Its action as a cholinergic agonist stimulates the iris sphincter muscle, resulting in a smaller pupil. This property, along with its ability to improve aqueous humor drainage, makes it valuable for treating glaucoma and presbyopia. Awareness of potential side effects and discussing medical history with a healthcare provider are important for patients using pilocarpine. Further information on its clinical use is available, such as through retrospective studies.

Frequently Asked Questions

Pilocarpine constricts the pupil because it is a cholinergic agonist that activates muscarinic receptors on the iris sphincter muscle, causing it to contract and narrow the pupil.

Miosis is the constriction or narrowing of the pupil, which pilocarpine causes. Mydriasis is the dilation or widening of the pupil, which is caused by mydriatic drugs, such as atropine.

Pilocarpine treats glaucoma by contracting the ciliary muscle, which pulls on the trabecular meshwork. This opens the eye's drainage angle, allowing excess fluid to drain and lowering intraocular pressure.

Yes, pilocarpine is also prescribed in oral tablet form to treat dry mouth (xerostomia) caused by Sjögren's syndrome or radiation therapy for head and neck cancer.

When used as eye drops, the pupil-constricting effect begins within 10 to 30 minutes, and the pressure-lowering effect occurs within 60 minutes.

Yes, pilocarpine can be used to constrict the pupil after a dilated eye exam, although this is not a routine procedure.

Yes, because it causes the pupil to shrink, pilocarpine reduces the amount of light entering the eye, which can make it more difficult to see in dim light or at night.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.